netherlands journal of critical care 28. Brause M, Neumann A, Schumacher T, Grabensee B, Heering P. Effect of filtration volume of continuous venovenous hemofiltration in the treatment of patients with acute renal failure in intensive care units. Crit Care Med 2003;31:841-846. 29. Gotloib L, Barzilay E, Shustak A, Wais Z, Jaichenko J, Lev A. Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. Resuscitation 1986;13:123-132. 30. Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002;30:100-106. 31. Laurent I, Adrie C, Vinsonneau C, Cariou A, Chiche JD, Ohanessian A, et al. High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol 2005;46:432-437. 32. Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, et al. Martin PY: Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006;70:1312-1317 33. Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G. Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 2004;50:102-109. 34. Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF. Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 1999;25:814-821. 35. Ratanarat R, Brendolan A, Piccinni P, Dan M, Salvatori G, Ricci Z, et al. Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 2005;9:R294-R302. 36. Cornejo R, Downey P, Castro R, Romero C, Regueira T, Vega J, et al. High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 2006;32:713-722. 37. Oudemans-vanStraaten HM, Bouman CS, Zandstra DF. Survival in acute renal failure. Intensive Care Med 2005;31:889-890. 38. Palevsky P. the Renal Failure Trial Network (ATN) study. http://www ATNStudy org. Accessed on August 2006. 39. Bellomo R. Augmented versus normal renal replacement therapy in severe acute renal failure. http:// www clinicaltrials gov/ct/show/NCT00221013?order=3. Accessed on August 2006. 40. Joannes-Boyau O: the IVOIRE study. www clinicaltrials gov/ct/show/NCT00241228?order=1. Accessed on August 2006. 41. Marshall MR, Golper TA, Shaver MJ, Chatoth DK. Hybrid renal replacement modalities for the critically ill. Contrib Nephrol 2001;252-257. 42. Kumar VA, Yeun JY, Depner TA, Don BR. Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report. Int J Artif Organs 2004;27:371-379. 43. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 2001;60:777-785. 44. Ronco C, Bellomo R. Basic mechanisms and definitions for continuous renal replacement therapies. Int J Artif Organs 1996;19:95-99. 45. Ricci Z, Ronco C, Bachetoni A, D’Amico G, Rossi S, Alessandri E, et al. Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion. Crit Care 2006;10:R67. 46. Canaud B, Garred LJ, Christol JP, Aubas S, Beraud JJ, Mion C. Pump assisted continuous venovenous hemofiltration for treating acute uremia. Kidney Int Suppl 1988;24:S154-S156. 47. Tam PY, Huraib S, Mahan B, LeBlanc D, Lunski CA, Holtzer C, et al. Slow continuous hemodialysis for the management of complicated acute renal failure in an intensive care unit. Clin Nephrol 1988;30:79-85. 48. Macias WL, Mueller BA, Scarim SK, Robinson M, Rudy DW. Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. Am J Kidney Dis 1991;18:451-458. 49. Storck M, Hartl WH, Zimmerer E, Inthorn D. Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 1991;337:452-455. 50. Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 2004;44:1000-1007. 51. Gasparovic V, Filipovic-Grcic I, Merkler M, Pisl Z. Continuous renal replacement therapy (CRRT) or intermittent hemodialysis (IHD)--what is the procedure of choice in critically ill patients? Ren Fail 2003;25:855-862. 52. Mehta RL, McDonald B, Gabbai FB, Pahl M, Pascual MT, Farkas A, et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001;60:1154-1163. 53. Uehlinger DE, Jakob SM, Ferrari P, Eichelberger M, Huynh-Do U, Marti HP, et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 2005;20:1630- 1637. 54. Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Boulain T, et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006;368:379-385. 55. Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M, Ramakrishnan N, et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 2002;28:29-37. 56. Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002;40:875-885. 57. Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002;30:2051-2058. 58. Guerin C, Girard R, Selli JM, Ayzac L. Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: results from a multicenter prospective epidemiological survey. Intensive Care Med 2002;28:1411-1418. 59. Bellomo R, Farmer M, Parkin G, Wright C, Boyce N. Severe acute renal failure: a comparison of acute continuous hemodiafiltration and conventional dialytic therapy. Nephron 1995;71:59-64. 60. Kruczynski K, Irvine-Bird K, Toffelmire EB, Morton AR. A comparison of continuous arteriovenous hemofiltration and intermittent hemodialysis in acute renal failure patients in the intensive care unit. ASAIO J 1993;39: M778-M781. 61. Gangji AS, Rabbat CG, Margetts PJ. Benefit of continuous renal replacement therapy in subgroups of acutely ill patients: a retrospective analysis. Clin Nephrol 2005;63:267-275. 62. van Bommel E, Bouvy ND, So KL, Zietse R, Vincent HH, Bruining HA, et al. Acute dialytic support for the critically ill: intermittent hemodialysis versus continuous arteriovenous hemodiafiltration. Am J Nephrol 1995;15:192-200. 63. Davenport A, Will EJ, Davison AM, Swindells S, Cohen AT, Miloszewski KJ, et al. Changes in intracranial pressure during machine and continuous haemofiltration. Int J Artif Organs 1989;12:439-444. 64. Davenport A, Will EJ, Davison AM, Swindells S, Cohen AT, Miloszewski KJ, et al. Changes in intracranial pressure during haemofiltration in oliguric patients with grade IV hepatic encephalopathy. Nephron 1989;53:142- 146. 65. Ronco C, Bellomo R, Brendolan A, Pinna V, La Greca G. Brain density changes during renal replacement in critically ill patients with acute renal failure. Continuous hemofiltration versus intermittent hemodialysis. J Nephrol 1999;12:173-178. 66. Van der SG, Diltoer M, Laureys M, Huyghens L. Intermittent hemodialysis in critically ill patients with multiple organ dysfunction syndrome is associated with intestinal intramucosal acidosis. Intensive Care Med 1996;22:747-751. 67. John S, Griesbach D, Baumgartel M, Weihprecht H, Schmieder RE, Geiger H. Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol Dial Transplant 2001;16:320-327. 568 neth j crit care • volume 10 • no 5 • october 2006
Bacteriën, opgepast! Krachtige, snelle en effectieve wondverzorging Met ACTICOAT krijgen bacteriën geen kans. Het unieke Nanokristallijn † Zilver pakt bacteriën snel (binnen 30 min.) en langdurig aan. Het ACTICOAT assortiment - speciaal voor de behandeling van geïnfecteerde wonden - is uitgebreid met ACTICOAT Moisture Control, een schuimkompres voorzien van een waterdichte toplaag, een sterk absorberende schuimkern en een zilvergecoate wondcontactlaag. Wondverzorging Smith & Nephew B.V., Postbus 525, 2130 AM, Hoofddorp T 020-6543999, F 020-6532099, E holland.info@smith-nephew.com www.smithnephew.nl www.acticoat.com Handelsmerk van Smith & Nephew TM SILCRYST is een handelsmerk van NUCRYST Pharmaceuticals Corp., gebruikt in licentie. † Nanokristallijn Zilver is een gepatenteerde technologie van NUCRYST Pharmaceuticals Corp.